Q2 2021 Results - Reimagining Medicine

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References Participants Vas Narasimhan Chief Executive Officer John Tsai Head of Global Drug Development and CMO Harry Kirsch Chief Financial Officer Richard Saynor CEO, Sandoz Marie-France Tschudin President, Novartis Pharmaceuticals Karen Hale Chief Legal Officer Susanne Schaffert President, Novartis Oncology Samir Shah Global Head Investor Relations 3 Investor Relations | Q2 2021 Results NOVARTIS | Reimagining Medicine

View entire presentation